These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 26081147

  • 21. Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility.
    Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM.
    Atherosclerosis; 2012 Feb; 220(2):443-8. PubMed ID: 22153699
    [Abstract] [Full Text] [Related]

  • 22. No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes.
    Huerta C, Sánchez-Ferrero E, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Alvarez V.
    Neurosci Lett; 2007 Feb 21; 413(3):202-5. PubMed ID: 17174475
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians.
    Punia S, Das M, Behari M, Mishra BK, Sahani AK, Govindappa ST, Jayaram S, Muthane UB, K TB, Juyal RC.
    Pharmacogenet Genomics; 2010 Jul 21; 20(7):435-41. PubMed ID: 20498626
    [Abstract] [Full Text] [Related]

  • 25. MTHFR C677T and eNOS G894T variants in preeclamptic women: Contribution to lipid peroxidation and oxidative stress.
    Rahimi Z, Malek-Khosravi S, Rahimi Z, Jalilvand F, Parsian A.
    Clin Biochem; 2013 Jan 21; 46(1-2):143-7. PubMed ID: 23103710
    [Abstract] [Full Text] [Related]

  • 26. Association between nucleotide-binding oligomerization domain protein 2 (NOD2) gene polymorphisms and Parkinson's disease (PD) susceptibility.
    Xu M, Zhang S, Zhao H, Ma C, Pan Y.
    Artif Cells Nanomed Biotechnol; 2019 Dec 21; 47(1):2134-2138. PubMed ID: 31146602
    [Abstract] [Full Text] [Related]

  • 27. Analysis of mutations and the association between polymorphisms in the cerebral dopamine neurotrophic factor (CDNF) gene and Parkinson disease.
    Choi JM, Hong JH, Chae MJ, Ngyuen PH, Kang HS, Ma HI, Kim YJ.
    Neurosci Lett; 2011 Apr 15; 493(3):97-101. PubMed ID: 21320571
    [Abstract] [Full Text] [Related]

  • 28. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
    Kumudini N, Umai A, Devi YP, Naushad SM, Mridula R, Borgohain R, Kutala VK.
    Indian J Biochem Biophys; 2013 Oct 15; 50(5):436-41. PubMed ID: 24772965
    [Abstract] [Full Text] [Related]

  • 29. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
    Das G, Misra AK, Das SK, Ray K, Ray J.
    Neurosci Lett; 2009 Aug 21; 460(1):16-20. PubMed ID: 19450659
    [Abstract] [Full Text] [Related]

  • 30. Dopamine β Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India.
    Ghosh A, Sadhukhan T, Giri S, Biswas A, Das SK, Ray K, Ray J.
    Neurosci Lett; 2019 Jul 27; 706():75-80. PubMed ID: 31082450
    [Abstract] [Full Text] [Related]

  • 31. Leads from xenobiotic metabolism genes for Parkinson's disease among north Indians.
    Punia S, Das M, Behari M, Dihana M, Govindappa ST, Muthane UB, Thelma BK, Juyal RC.
    Pharmacogenet Genomics; 2011 Dec 27; 21(12):790-7. PubMed ID: 22016051
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration.
    Venturelli E, Villa C, Scarpini E, Fenoglio C, Guidi I, Lovati C, Marcone A, Cortini F, Scalabrini D, Clerici F, Bresolin N, Mariani C, Cappa S, Galimberti D.
    Eur J Neurol; 2008 Jan 27; 15(1):77-81. PubMed ID: 18042235
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.
    Shahabi HN, Westberg L, Melke J, Håkansson A, Belin AC, Sydow O, Olson L, Holmberg B, Nissbrandt H.
    J Neural Transm (Vienna); 2009 May 27; 116(5):567-73. PubMed ID: 19381774
    [Abstract] [Full Text] [Related]

  • 39. Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms With Acute Rejection in Liver Transplant Recipients.
    Azarpira N, Namazi S, Malahi S, Kazemi K.
    Exp Clin Transplant; 2016 Jun 27; 14(3):307-12. PubMed ID: 26102207
    [Abstract] [Full Text] [Related]

  • 40. Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.
    Juyal RC, Das M, Punia S, Behari M, Nainwal G, Singh S, Swaminath PV, Govindappa ST, Jayaram S, Muthane UB, Thelma BK.
    Neurogenetics; 2006 Nov 27; 7(4):223-9. PubMed ID: 16816977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.